At the June 2011 Drug Information Association Annual Meeting, NPC asked Dr. Marcel Salive for his thoughts on how comparative effectiveness research (CER) is considered in Medicare coverage determinations, and how the National Institutes of Health (NIH) is looking to incorporate CER into the type of research that they do. Dr. Salive is with the Division of Geriatrics and Clinical Gerontology, National Institute on Aging, NIH.
Link to this comment:
All Comments (0)